Company / Capital Expenditures
Baxter International Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$513.0M
FY2025
5-year range
$377.0M / $691.0M
FY2021-FY2025
Trend
+15.0%
vs FY2024
Sector context
#24 of 151
Health Care
What the data says
Baxter International's capital expenditures of $513M is higher than 84% of companies in the Health Care sector (FY2025). Capital Expenditures has increased for 3 consecutive years, from $377M in FY2022 to $513M in FY2025.
Based on SEC 10-K filings.
$513M in FY2025 with a 5-year CAGR of -6.3%. Top quartile in the Health Care sector.
Improved from $432M to $513M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +10.8%
- 5-Year CAGR
- -6.3%
- 10-Year CAGR
- -
Sector benchmark
+88.8% above sector average
Key checks
Key Insights
- Baxter International's capital expenditures has grown for 3 consecutive years.
- 5-year CAGR of -6.3%, indicating a declining trend.
- In FY2025, capital expenditures increased 15.0% year-over-year.
- Ranks #24 out of 151 companies in the Health Care sector.
Company context
Key Data Points
- Negative profit margin: -6.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $513.0M | +15.0% |
| FY2024 | $446.0M | +3.2% |
| FY2023 | $432.0M | +14.6% |
| FY2022 | $377.0M | -45.4% |
| FY2021 | $691.0M | -2.5% |
| FY2020 | $709.0M | +15.1% |
| FY2019 | $616.0M | -6.5% |
| FY2018 | $659.0M | +7.0% |
| FY2017 | $616.0M | -33.4% |
| FY2016 | $925.0M | +1.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026